Study | Effect under investigation | Protocol | Results |
---|
CORTES-FRANCO & al. (2002) | Photoprotection against ultraviolet radiation | 45 healthy volunteers, single‐blind controlled clinical trial, 3 groups over 1 week: Group 1: d‐alpha‐tocopherol 1,200 IU/day; Group 2: ascorbic acid 2 g/day; Group 3: combination of vitamin E 1,200 IU + vitamin C 2 g/day. Evaluation: minimal erythema dose (MED). | Median increase in MED: Group 1: +5 mJ/cm²; Group 2: 0; Group 3 (combination): +20 mJ/cm². The best photoprotective effect was observed with the vitamin E + C combination. |
KORKINA & al. (2009) | Psoriasis | 58 patients with psoriasis, supplemented for 30–35 days with coenzyme Q10 (50 mg/day), vitamin E (50 mg/day) and selenium (48 µg/day) dissolved in soy lecithin versus placebo. Assessment: clinical parameters and oxidative stress markers (superoxide, SOD, catalase, nitrites/nitrates). | Significant and more rapid clinical improvement, normalisation of oxidative stress markers compared with placebo (regulation of antioxidant enzymes, reduction in plasma nitrites and nitrates). |
HAY & al. (2010) | Hair growth | 38 volunteers suffering from hair loss underwent oral supplementation for eight months: two capsules per day (placebo or vitamin E: 50 mg tocotrienols + 15.43 mg α-tocopherol). | +15.2% in hair count after 4 months and +34.5% after 8 months (vitamin E group) versus +3.2% after 4 months and –0.1% after 8 months (placebo group). |
MIRSHAFIEY & al. (2011) | Atopic dermatitis | 45 patients, randomised, double-blind, placebo-controlled study. Four groups over 60 days: placebo (n=11), vitamin D3 alone (1600 IU, n=12), vitamin E alone (600 IU α-tocopherol, n=11), combination D3 + E (n=11). Assessment: SCORAD (dermatitis severity score). | SCORAD reduction: –34.8% (group D), –35.7% (group E), –64.3% (group DE). Both objective and subjective improvements were confirmed. |
KIMBERLY & al. (2017) | Acne | 168 participants, supplementation for three months: two capsules daily of lactoferrin, vitamin E and zinc (n=82) versus placebo (n=82). | Active treatment group: median lesion reduction as early as two weeks (–14.5%), reaching a maximum at ten weeks (–28.5%). Comedones decreased by 32.5% and inflammatory lesions by 44%. No improvement was observed in the placebo group. |
CZAJKOWSKI & al. (2023) | Vitiligo | 46 patients with non-segmental vitiligo for more than one year. Three groups were formed: UVB alone (three times per week for four months), vitamin A (5,000 IU) plus vitamin E (400 mg), or a combination of UVB and vitamins. | Increased antioxidant enzyme levels and reduced oxidative stress across all groups. Enhanced repigmentation (VASI score) and improved quality of life (DLQI score) were observed in the UVB + vitamins combination group (VASI −6.95 ± 4.69; DLQI −1.90 ± 2.77). |